Intralymphatic Immunotherapy With Autologous Semen in a Korean Man With Post-Orgasmic Illness Syndrome

@article{Kim2018IntralymphaticIW,
  title={Intralymphatic Immunotherapy With Autologous Semen in a Korean Man With Post-Orgasmic Illness Syndrome},
  author={T. B. Kim and Young Sup Shim and S. D. Lee and E. S. Son and Jung Woo Shim and S. P. Lee},
  journal={Sexual Medicine},
  year={2018},
  volume={6},
  pages={174 - 179}
}
  • T. B. Kim, Young Sup Shim, +3 authors S. P. Lee
  • Published 2018
  • Medicine
  • Sexual Medicine
  • Post-orgasmic illness syndrome (POIS) is a very rare disease characterized by local allergic symptoms and transient flu-like illness that nearly always occur after masturbation, coitus, or spontaneous ejaculation and last for 2 to 7 days. In a previous case report, 2 patients with POIS received hyposensitization therapy composed of multiple subcutaneous injections of autologous semen that resulted in a gradual decrease of symptoms. However, this procedure requires patients to endure pain and… CONTINUE READING
    10 Citations
    Immunophenotypical Characterization of a Brazilian POIS (Post-Orgasmic Illness Syndrome) Patient: Adding More Pieces to Puzzle
    • Highly Influenced
    Clinical experience with post-orgasmic illness syndrome (POIS) patients—characteristics and possible treatment modality
    • Y. Reisman
    • Medicine
    • International Journal of Impotence Research
    • 2020
    • 2
    Post orgasmic illness syndrome: what do we know till now?
    • 2

    References

    SHOWING 1-10 OF 11 REFERENCES
    Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2).
    • 34
    • Highly Influential
    Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    • 195
    • Highly Influential
    A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies
    • 20
    • PDF
    Postorgasmic Illness Syndrome: Two Cases
    • 47
    Allergen-specific intralymphatic immunotherapy in human and animal studies
    • 9
    • PDF